跳至主要内容
临床试验/IRCT20220815055705N1
IRCT20220815055705N1招募中3 期

evaluation of resveratrol effect on the expression of the apoptosis-associated genes in granulosa cells of PCOS patients applicant to ART (triple-blinded randomized controlled trial)

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • patients must be infertile due to PCOS and aged between 18 and 40.
  • PCOS is diagnosed based on Rotterdam criteria and having 2 of 3 criteria is enough for diagnosis: amenorrhea or oligomenorrhea, clinical or biochemical hyperandrogenism manifestations, observation of cysts in ovary sonography (at least 12 follicles with diameter of 2 - 9 mm or an increase in ovary volume more than 10cm in tans-vaginal ultrasound radiography).

排除标准

  • adrenal hyperplasia
  • androgen secreting tumors
  • hyperprolactinemia
  • thyroid malfunction
  • diabetes/glucose intolerance
  • male infertility factors
  • taking anti-oxidant supplements less than 6 months prior to entering the study.
  • taking ovulation stimulating drugs less than 6 months prior to entering the study.
  • taking drugs with effect on hormone profile less than 6 months prior to entering the study.

研究者

相似试验